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Abstract
Background Currently, Roux-en Y gastric bypass (RYGB)
is the most efficient therapy for severe obesity. Weight
loss after surgery is, however, highly variable and genet-
ically influenced. Genome-wide association studies have
identified several single nucleotide polymorphisms (SNP)
associated with body mass index (BMI) and waist-hip
ratio (WHR). We aimed to identify two genetic risk scores
(GRS) composed of weighted BMI and WHR-associated
SNPs to estimate their impact on excess BMI loss
(EBMIL) after RYGB surgery.
Methods Two hundred and thirty-eight obese patients
(BMI 45.1 ± 6.2 kg/m2, 74 % women), who underwent
RYGB, were genotyped for 35 BMI and WHR-associated
SNPs and were followed up after 2 years. SNPs with high
impact on post-surgical weight loss were filtered out using
a random forest model. The filtered SNPs were combined
into a GRS and analyzed in a linear regression model.
Results An up to 11 % lower EBMIL with higher risk score
was estimated for twoGRSmodels (P=0.026 resp. P=0.021)
composed of seven BMI-associated SNPs (closest genes:
MC4R, TMEM160, PTBP2, NUDT3, TFAP2B, ZNF608,
MAP2K5, GNPDA2, and MTCH2) and of three WHR-
associated SNPs (closest genes: HOXC13, LYPLAL1, and
DNM3-PIGC). Patients within the lowest GRS quartile had
higher EBMIL compared to patients within the other three
quartiles in both models.
Conclusions We identified two GRSs composed of BMI and
WHR-associated SNPs with significant impact on weight loss
after RYGB surgery using random forest analysis as a SNP
selection tool. The GRS may be useful to pre-surgically eval-
uate the risks for patients undergoing RYGB surgery.
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Introduction
While obesity is today one of the world leading health
problems, treatment options for obese patients remain lim-
ited. Roux-en Y gastric bypass (RYGB) surgery is cur-
rently one of the most efficient therapy alternatives for
sustainable weight loss in obese patients [1]. However,
the degree of weight loss and treatment success is highly
variable and potential surgery-associated complications
should not be underestimated [2–4]. Thus, the detection
of reliable pre-surgical indicators for a risk-benefit assess-
ment before the intervention would be of high value.
Weight loss following RYGB surgery is influenced by
genetic variants [5]. Large genome-wide association stud-
ies (GWAS) have detected several single nucleotide poly-
morphisms (SNP) that are associated with BMI and waist-
hip ratio (WHR) [6–8]. It cannot be excluded that the
genetic variants factors associated with BMI may have
an influence on Roux-en Y surgery induced weight loss.
The fat mass and obesity associated gene (FTO) has
the strongest association to BMI as shown in a study
including more than 340,000 people [7]. However, the
explained variance of the FTO effect allele was earlier
published to be only 0.34 % [8], meaning that the remain-
ing individual variance in BMI may be attributed to other
genetic and non-genetic factors. Genetic risk scores
(GRS) describe the collective impact of several potentially
risk contributing SNPs by creating one continuous vari-
able that indicates the likelihood to develop a disease or a
trait, such as weight loss [9]. GRSs are calculated in a
weighted or unweighted manner. While weighted GRS
take the previously reported effect from of each individual
SNP into account, unweighted GRS consider only the
number of alleles of each SNP included in the calculation
[10–12]. In the present study, we investigated the impact
of BMI and WHR-associated SNPs on excess BMI loss
(EBMIL) 2 years after RYGB surgery. Based on a selec-
tion of genetic variants, we developed a weighted GRS
and estimated the post-surgery weight loss in dependency
of the considered risk variants. To select SNPs having a
relevant impact on EBMIL, the random forest statistical
method was used [13]. This machine learning tool has
been used previously to screen or reduce dimensions in
large GWAS datasets [14–17]. In the current study, this
statistical method is used for the first time to analyze and




Two hundred and thirty-eight obese patients, characterized by
a BMI >30 kg/m2, were included in the study (mean±SD; age
43.2±10.8, initial BMI 45.1±6.2 kg/m2, 74 % women). All
patients were weighted in the morning in a fasted state with
light clothes but no shoes on. All participants underwent prox-
imal or distal RYGB surgery at the Interdisciplinary Obesity
Center, St. Gallen, Switzerland, and returned 2 years later to
the study center for a follow-up investigation. Weight loss
after surgery was determined as EBMIL, considering a BMI
>25 kg/m2 as excess. The relative EBMIL was calculated as
100 − [(final BMI − 25/initial BMI − 25) * 100] [18].
Demographic and clinical characteristics of the study popula-
tion are summarized in Table 1. Percent BMI loss was calcu-
lated according to [18] and was used as a confirmatory inde-
pendent variable in genetic association analyses.
The cohort and both bariatric procedures have earlier been
described in detail [19]. In brief, a gastric pouch of about 20–
30 ml was created after removing a major part of the stomach.
The length to the biliopancreatic limb was set to approximate-
ly 60 cm in the proximal RYGB procedure and 60 to 100 cm
in the distal procedure. Patients who obtained the operation for
a second time or underwent an alternative intervention to
RYGB surgery (e.g., gastric banding) were not included.
Genotyping
Genotyping was performed by the SNP&SEQ Technology





Included patients, n 238
Sex, n (% cohort)
Female 173 (73)
Male 65 (27)
Agea, years (SD) 43.1 (±10.8)
BMIa, kg/m2 (SD) 45.1 (±6.2)
Surgery type, n (% followed up cohort)
Distal RYGB 175 (73.5)
Proximal RYGB 63 (26.5)
BMIb, kg/m2 (SD) 28.5 (±3.9)
EBMILb, % (SD) 83.8 (±17.8)
BMI lossb, % (SD) 36.3 (±8.4)
EBMIL excess BMI loss, RYGB Roux-en
Y gastric bypass
a At baseline
bAt 24-month post-Roux-en Y gastric by-
pass surgery
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iSelect genotyping array (Illumina Inc.). All determined SNPs
were in Hardy-Weinberg equilibrium. None of the variants
were in linkage disequilibrium. Twenty-three BMI-associated
and 12 WHR-associated SNPs were chosen for genotyping
out of large GWAS, reporting the SNPs’ association to BMI,
respectively, WHR [6, 8]. Further, a minor allele frequency of
>15 % was required. The full list of determined genetic vari-
ants is presented in Supplementary table 1.
Statistics
The genotype of each SNP was coded based on the
amount of effect alleles, i.e., 0 for no effect alleles, one
for heterozygote carriers, and two for individuals carrying
two effect alleles. Subsequently, SNP-associated beta-
values as published by Speliotes et al. and Heid et al.
were multiplied with the amount of alleles to obtain
weighted SNP scores. Weighted scores were included in
the random forest model [13] as predictors and EBMIL as
the target variable. Ten thousand random decision trees
were created. The random forest model result for the
weighted BMI-associated SNPs showed, when plotted, a
clear change in mean squared error (MSE) around 10 %
(Supplementary figure 1a). SNPs above 10 % MSE were
considered having a relevant influence on the model and
were chosen for inclusion in the genetic risk score. The
change in MSE was also seen in the random forest results
for the weighted WHR SNPs, although not as clear. The
cut off for 10 % was therefore used in that model as well.
The trajectory direction for each SNP with a MSE >10 %
(i.e., if the SNP increased or decreased EBMIL) was test-
ed by performing a preliminary linear regression analysis.
The coding of a BMI or WHR-associated SNP was
inverted in case an association with EBMIL increase
was detected.
GRS were calculated by summing up the weighted SNP
scores for all variants that induced a MSE >10 % in the ran-
dom forest model according to the following formula: ∑n
effect allelesSNPi × beta valueSNPi (i=number of included
SNPs in the model, n=number of risk alleles). The GRSs
were used as continuous variables in a multiple linear regres-
sion with EBMIL as the dependent variable, adjusting for age,
sex, initial BMI, and surgery type. Student’s t test was used in
the post hoc analysis to compare the strength of weight loss
between GRS quartiles. P values <0.05 were considered sig-
nificant and, if necessary, adjusted for multiple testing accord-
ing to Benjamini-Hochberg (BH) with the Q-level of 5 % [20].
Analyses were performed using the CRAN package BRattle^
(Williams G. Data Mining with Rattle and R: The Art of
Excavating Data for Knowledge Discovery.; 2011) in R studio
(R Core Team, Vienna, Austria) and SPSS Statistics for
Windows, Version 22.0 (IBM Corp. Released 2013. IBM.
Armonk, NY: IBM Corp.).
Results
Clinical Outcome
Patients showed an average EBMIL of 84 % (SD 18 %)
2 years after RYGB surgery. Younger patients and patients
with lower initial BMI benefitted most from the intervention
according to regression analyses correcting for age, BMI, sex,
and surgery type (β = −0.23, P < 0.031 resp. β = −0.73,
P<0.001). Men and women showed a similar EBMIL. The
surgery type did not have a significant effect on EBMIL in this
cohort. However, we observed a significant difference in the
average percentage of individual BMI loss 2 years after
RYGB surgery in dependency of proximal or distal surgery
(P=0.045). The percentage loss in BMI was stronger in indi-
viduals undergoing distal RYGB surgery (33.1 %) compared
to patients who underwent the proximal surgery approach
(36.7 %).
Outcome of Random Forest Analyses
Two random forest models were developed to evaluate the
impact of genetic variants on EBMIL. In the first model 23
BMI-associated SNPswere included (RFMwBMI) [8]. The sec-
ond model considered 12 WHR-associated SNPs
(RFMwWHR) [6]. As shown in Table 2, seven variants associ-
ated with BMI and three variants associated with WHR in-
duced a >10 % MSE and were considered in the subsequent
calculation of GRS scores.
Impact of GRSs on EBMIL After RYGB Surgery
The first model, RFMwBMI, consisting of BMI-associated
SNPs, generated seven SNPs that were included in the BMI
SNP-based GRS (GRSwBMI, closest genes: MC4R,
TMEM160, PTBP2, NUDT3, TFAP2B, ZNF608, MAP2K5,
GNPDA2, and MTCH2). The included patients showed
GRSwBMI ranging from 3 to 37, thereby carrying at least one
risk allele and up to one risk allele in each of the seven genes.
The GRSwBMI was significantly associated with EBMIL
(β=−0.32, P=0.026) in the multiple linear regression model
adjusting for age, sex, initial BMI, and surgery type, indicat-
ing a 0.32 % decrease of EBMIL per score unit. Maximum
and minimum GRSwBMI scores were associated with 83 and
89 % EBMIL, respectively (Fig. 1a). The results were con-
firmed in linear regression analyses showing a significant im-
pact of GRSwBMI on percent BMI loss (β=−0.14, P=0.034).
Investigated SNPs and associated genes are shown in Table 2.
RFMwWHR detected three weightedWHR-associated SNPs
(closest genes: HOXC13, LYPLAL1, and DNM3-PIGC) in-
ducing a 10 % MSE >10 % that were included into a GRS
composed of WHR-associated SNPs (GRSwWHR). The gener-
ated GRSwWHR ranged from 0 to 19 and was associated with
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EBMIL using multiple linear regression analysis (β=−0.59,
P=0.021). Maximum and minimum GRSwWHR scores were
associated with 78 and 89 % EBMIL, respectively (Fig. 1b).
The findings were confirmed in regression analyses showing
an association between GRSwWHR and percent BMI loss
(β=−0.29, P=0.028).
Quartile Analysis of the GRSs
To further analyze associations between the genetic com-
position and post-operative EBMIL, patients were divided
into four quartiles based on their GRS. The score quartiles
of GRSwBMI and GRSwWHR were entered as a factor in
two independent multiple linear regression analyses,
correcting for age, sex, initial BMI, and surgery type. In
both models, the lowest GRS quartile was associated with
a significantly higher EBMIL in contrast to the other
quartiles (GRSwBMI: BH-adjusted P < 0.027, GRSwWHR:
BH-adjusted P< 0.048; Fig. 2a, b). Similar results were
obtained when regressing quartiles of the GRSs against
percent BMI loss. In contrast to GRSwWHR quartiles,
GRSwBMI quartiles showed a significant linear association
with percent BMI loss (P= 0.007 resp. P= 0.051). Further,
patients in the first quartile lost more total BMI compared
to the other quartiles (GRSwBMI: BH-adjusted P< 0.021,



























Fig. 1 The genetic risk scores (GRS), calculated on the basis of weighted
single nucleotide polymorphisms associated with BMI (a GRSwBMI) and
waist-hip ratio (b GRSwWHR) estimated an up to 11 % difference in
excess BMI loss (EBMIL) after Roux-en Y gastric bypass surgery
with increasing risk score for both models. Each GRS was inserted
individually in an adjusted multiple linear regression with EBMIL as
the independent variable. a GRSwBMI included genetic variants of
MC4R, TMEM160, PTBP2, NUDT3, TFAP2B, ZNF608, MAP2K5,
GNPDA2, and MTCH2 and had a significant impact on EBMIL in a
multilinear regression model adjusting for age, sex, initial BMI, and
surgery type (P value of 0.026, line equation; y= 1.1–0.32x; R2 = 0.181.
b GRSwWHR consisted of variants within or near by the genes HOXC13,
LYPLAL1, and DNM3-PIGC, P= 0.021, line equation; y= 89.4–0.59x;
R2 = 0.071
Table 2 Genetic variances










rs571312 MC4R A A C 23.16
rs3810291 TMEM160 G A G 19.65
rs1555543 PTBP2 A C A 18.58
rs206936 NUDT3 G G G 17.58
rs987237 TFAP2B G G G 17.49
rs4836133 ZNF608 A A A 17.12




rs1443512 HOXC13 A A A 13.15
rs4846567 LYPLAL1 A G G 11.24
rs1011731 DNM3-
PIGC
G G A 10.32
The listed single nucleotide polymorphisms (SNP) induced a mean squared error (MSE) above 10 % in the
random forest model. These variants were subsequently included in the respective GRS model (weighted BMI
model (GRSwBMI) andweighted waist-hip ratiomodel (GRSwWHR)). Those alleles were defined as risk alleles that
contributed least to the weight loss following Roux-en Y gastric bypass surgery. Interestingly, the A allele of the
TMEM160-related SNP rs3810291 was reported to be associated with higher BMI by Speliotes et al. In our study,
the allele, G, is associated with EBMIL
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Discussion
In the present study, we demonstrate that weight loss (EBMIL)
2 years after RYGB surgery is inversely associated with two
genetic risk scores composed of BMI and WHR-associated
SNPs. This is the first study that developed genetic risk scores
to investigate the impact of common BMI and WHR-associated
SNPs on post-operative EBMIL after RYGB surgery using the
random forest method as a novel selection approach for relevant
SNPs. The EBMIL was up to 11 % different in dependency of
SNP composition in both the BMI-associated and the WHR-
associated model. These findings suggest a relevant and additive
effect of genetic variants on RYGB, translating into about 1.9 kg/
m2 average weight loss. Speliotes et al. [8] reported a per-allele
impact of 0.17 kg/m2 for the strongest BMI-associated SNP,
FTO. Our observations strengthen the hypothesis that the con-
sideration of several risk SNPs helps to estimate post-operative
weight response more accurately than isolated genetic variants
and can be considered as a complement to the predictive clinical
factors such as age and initial BMI.
Patients with the lowest genetic risk scores (in quartile 1; Q1)
had a significantly higher EBMIL, compared to higher scoring
patients in quartiles 2 to 4 (Fig. 2a, b). This observation supports
the hypothesis that patients carrying none or only a small number
of the risk alleles show a more efficient weight loss following
RYGB surgery than carriers of multiple risk variants.
Interestingly, increasing GRS do not seem to interfere propor-
tionally with EBMIL, as the impact of GRS quartiles 2, 3, and 4
on EBMIL did not differ significantly (Fig. 2). This observation
indicates that the risk alleles do not follow a strictly linear effect
pattern. All tests were also performed for percent BMI loss as the
independent variable and led to similar results.
Earlier studies showed that the type of surgery may have a
significant impact on weight loss efficacy [21]. Therefore, we
included the type of surgery as important covariate in our regres-
sion models, when evaluating the genetic risk scores that we
developed. While we did not observe significant differences in
EBMIL dependent on the surgery type, we did observe a signif-
icant better outcome in percentage BMI change 2 years after
distal surgery. These results suggest that distal surgery may in-
duce an efficient individual effect on weight loss, from which
especially strongly obese patients may profit, despite the fact that
the overall rate in EBMIL appears not to be significantly different
in proximal and distal surgery.
Not all previously reported effect alleles linked to BMI and
WHR in GWAS correspond to the effect allele reported in this
study (Table 2). The observed differences in effect may be attrib-
uted to the difference in the investigated trait, i.e., BMI investi-
gated in other studies compared to EBMIL investigated in our
study. Furthermore, external factors, such as exercise, may im-
pact the strength of association between SNP and trait as, e.g.,
observed for the gene FTO [22].
Potential Mechanisms
We report that a combination of risk alleles is linked to weight
loss following RYGB surgery. When analyzing GRSwBMI and
GRSwWHR-associated genes with the online tools g:Profiler [23]
or String [24] for pathway analysis (and all originally included
SNP-associated genes as background), no common known bio-
logical pathways were detected, suggesting that weight regula-
tion is impacted via several not directly interfering signaling
routes. All genes included in the developedGRS have previously
been linked to higher BMI or WHR [6, 8]. Furthermore, we and
others could show that three of these genes, namely MC4R,
TFAP2B, andLYPLAL1, are associatedwithweight loss [25–28].
Melanocortin receptor 4 (MC4R) has been implicated in eat-

































a bFig. 2 Quartiles of the genetic
risk scores (GRS) indicate that
patients with none or very few
risk alleles have a higher expected
excess BMI loss (EBMIL)
following RYGB surgery than
patients with a higher number of
risk alleles. GRSs quartiles were
inserted as factors in an adjusted
multiple linear regressions with
EBMIL as the independent
variable. a In GRSwBMI Q1, the
mean EBMIL was with 89 %
significantly different from the
means of Q2, Q3, and Q4 (79 to
83 %), Benjamini Hochberg-
adjusted P< 0.027. b GRSwWHR
Q1 corresponded to a mean
EBMIL of 89 % compared to 81
to 82 % in Q2–Q4 (Benjamini
Hochberg-adjusted P< 0.048).
*P< 0.05, **P< 0.01
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agonists alpha- and beta-MSH, which is antagonized by agouti
gene-related peptide in the hypothalamus regulating energy in-
take [29]. Studies investigating the impact of common MC4R
SNPs on bariatric surgery outcome led to contradictory results
[30–33]. Activating enhancer binding protein 2 beta (TFAP2B)
and lysophospholipase-like 1 (LYPLAL1) have not been linked
yet to post-surgery weight loss. However, in a meal intervention
study, the TFAP2B-associated SNP rs987237 was linked to
weight loss in the high-fat diet group [27]. LYPLAL1 is expressed
in regions known to regulate energy metabolism such as the
hypothalamus and brain stem [34–36]. LYPLAL1was associated
with weight loss effects in obese patients undergoing lifestyle
changes [28]. The SNP rs4846567 close to LYPLAL1 is located
within an insulator segment, which may interfere with the
promoter-enhancer interaction and/or block the propagation of
heterochromatic structures and DNA-methylation in adjacent
chromatin [37]. It can be speculated that the SNP leads to a less
available promoter region and consecutively to an altered
expression.
Strengths and Limitations
Previous studies that aimed to define a genetic risk score for
weight loss following RYGB did not lead to significant results.
These studies summed all putative risk alleles to a GRS without
applying a filtering step that allows identifying genetic variants
with high impact on the investigated trait [1, 38]. Our approach
using the random forest method to detect SNPs with high impact
on the outcome variable appears to be an efficient and sensitive
way to select relevant SNPs for the subsequently performed as-
sociation analysis. It would be of value to confirm the obtained
results in a larger cohort of RYGB patients.
Conclusions
Using random forest analysis as a SNP selection tool, we defined
two GRSs composed of weighted BMI and WHR-associated
SNPs, respectively, which are significantly associated with
EBMIL after RYGB surgery. A pre-surgical determination of
the GRS will help to pre-surgically evaluate to what extent pa-
tients may profit from RYGB surgery.
BMI, body mass index; DNM3, dynamin 3-phosphatidy
linositol glycan anchor biosynthesis, class c; EBMIL, excess
BMI loss; GNPDA2, glucosamine-6-phosphate deaminase 2;
GRS, genetic risk score;GWAS, genome wide association study;
HOXC13, homeobox c13; LYPLAL1, lysophospholipase-like 1;
MAP2K5, mitogen-activated protein kinase kinase 5; MC4R,
melanocortin 4 receptor; MSE, mean standard error; MTCH2,
mitochondrial carrier 2; NUDT3, nudix-type motif 3; PTBP2,
polypyrimidine tract binding protein 2; RFM, random forest
model; RYGB, Roux-en Y gastric bypass; SNP, single nucleotide
polymorphism; TFAP2B, activating enhancer binding protein 2
beta; TMEM160, transmembrane protein 160; WHR, waist-hip
ratio; ZNF608, zinc finger protein 608.
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